1. The proto CpG island methylator phenotype of sessile serrated adenomas/polyps
   Hannah R. Parker et al, 2018, Epigenetics CrossRef
2. B-RAF mutation and accumulated gene methylation in aberrant crypt foci (ACF), sessile serrated adenoma/polyp (SSA/P) and cancer in SSA/P
   A Inoue et al, 2015, British Journal of Cancer CrossRef
3. Promoter methylation of human mutL homolog 1 and colorectal cancer risk
   Bian Shi et al, 2018, Journal of Cancer Research and Therapeutics CrossRef
4. Loss of Hes1 Differentiates Sessile Serrated Adenoma/Polyp From Hyperplastic Polyp
   Min Cui et al, 2016, American Journal of Surgical Pathology CrossRef
5. DNA methylation changes that precede onset of dysplasia in advanced sessile serrated adenomas
   Cheng Liu et al, 2019, Clinical Epigenetics CrossRef
6. Establishing a Biological Profile for Interval Colorectal Cancers
   Amy L. Cisyk et al, 2014, Digestive Diseases and Sciences CrossRef
7. CpG Island Methylation in Sessile Serrated Adenomas Increases With Age, Indicating Lower Risk of Malignancy in Young Patients
   Cheng Liu et al, 2018, Gastroenterology CrossRef
8. Inflammatory response in serrated precursor lesions of the colon classified according to WHO entities, clinical parameters and phenotype–genotype correlation
   Tilman T Rau et al, 2016, The Journal of Pathology: Clinical Research CrossRef
9. Immune environment in serrated lesions of the colon: intraepithelial lymphocyte density, PD-1, and PD-L1 expression correlate with serrated neoplasia pathway progression
   Gabriel Acosta-Gonzalez et al, 2019, Human Pathology CrossRef
10. Can the rate and location of sessile serrated polyps be part of colorectal Cancer disparity in African Americans?
    Mehdi Nouraie et al, 2019, BMC Gastroenterology CrossRef
11. Prevalence, risk factors, and BRAF mutation of colorectal sessile serrated lesions among Vietnamese patients
    Nhu Thi Hanh Vu et al, 2024, World Journal of Clinical Oncology CrossRef
12. Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway
    Eiji Sakai et al, 2016, International Journal of Cancer CrossRef
13. Receptor tyrosine kinase fusions act as a significant alternative driver of the serrated pathway in colorectal cancer development
    Anthony W‐H Chan et al, 2020, The Journal of Pathology CrossRef
14. Clinicopathological factors associated with BRAF‐V600E mutation in colorectal serrated adenomas
    Antonio Travaglino et al, 2019, Histopathology CrossRef
15. DNA methylation alterations of AXIN2 in serrated adenomas and colon carcinomas with microsatellite instability
    Yuta Muto et al, 2014, BMC Cancer CrossRef
16. TP53 mutation at early stage of colorectal cancer progression from two types of laterally spreading tumors
    Eiji Sakai et al, 2016, Cancer Science CrossRef
17. DNA methylation accumulation and its predetermination of future cancer phenotypes
    A. Kaneda et al, 2014, Journal of Biochemistry CrossRef
18. Clinical, Pathological, and Molecular Characteristics of CpG Island Methylator Phenotype in Colorectal Cancer: A Systematic Review and Meta-analysis
    Shailesh M. Advani et al, 2018, Translational Oncology CrossRef
19. Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer
    Shailesh Mahesh Advani et al, 2019, BMC Cancer CrossRef
20. Cell-surface markers for colon adenoma and adenocarcinoma
    Kamini Sewda et al, 2016, Oncotarget CrossRef
21. Evolving pathologic concepts of serrated lesions of the colorectum
    Jung Ho Kim et al, 2020, Journal of Pathology and Translational Medicine CrossRef
22. The CIMP Phenotype inBRAFMutant Serrated Polyps from a Prospective Colonoscopy Patient Cohort
    Winnie C. Fernando et al, 2014, Gastroenterology Research and Practice CrossRef